Urinary Retention: Clinical Trials

11 trials for Urinary Retention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 terminated, 2 unknown, 1 recruiting. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 4, Terminated 4, Unknown 2, Recruiting 1

Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy of the Addition of Magnesium Sulfate to Morphine on the Occurrence of Acute Urinary Retention Following Epidural Anesthesia for Cesarean Section.
Injection of 500 mg magnesium sulfate + 2 mg morphine into the epidural space, Injection of Isotonic saline + 2 mg morphine into the epidural space - Urinary Retention
Phase 4RecruitingCHU de Reims2902025-01-162025-12-30
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
Sugammadex, Neostigmine, Glycopyrrolate - Spine Surgery, Reversal of Neuromuscular Blockade
Phase 4CompletedUniversity of Missouri-Columbia1182023-08-032026-10-07
The Effect of Tamsulosin on Postoperative Urinary Retention
Tamsulosin, Placebo - Urinary Retention
Phase 4TerminatedWake Forest University Health Sciences42021-10-192024-01-31
Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin
Tamsulosin Hydrochloride - Thoracic Diseases, Urinary Retention
Phase 4TerminatedUniversity of Massachusetts, Worcester1092021-08-012024-11-07
Study to Prevent Postoperative Urinary Retention
TAMSULOSIN Mepha Ret Depocaps 0.4 mg, Control Intervention - Urinary Retention, Inguinal Hernia
Phase 4TerminatedAntonio Nocito, MD3122020-11-012026-02-17
Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty
Tamsulosin, Placebo Oral Tablet - Urinary Retention Postoperative, Arthropathy of Knee
Phase 4CompletedKantonsspital Graubünden1702019-08-012025-09-03
Assessing Pyridium for Post-Sling Urinary Retention
Phenazopyridine - Urinary Retention
Phase 4CompletedIcahn School of Medicine at Mount Sinai982017-10-242019-10-29
Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
Nitrofurantoin 100 MG, Placebo Oral Tablet - Catheter-Associated Urinary Tract Infection
Phase 4CompletedWake Forest University Health Sciences1642017-09-292022-08-09
Hernia Surgery Urinary Retention
Tamsulosin - Hernia, Urinary Retention
Phase 4UnknownMemorial Health University Medical Center1402017-01-132018-03-23
Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients
Green light PVP, Prostatic artery embolization - Benign Prostate Hyperplasia, Urinary Retention
Phase 4UnknownRoyal Victoria Hospital, Canada732013-12-012014-11-04
An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures
ezogabine/retigabine - Epilepsy
Phase 4TerminatedGlaxoSmithKline102013-03-272020-12-04

Narrower conditions

Urinary Tract Infections (2)  ·  Epilepsy (1)  ·  Hernia (1)  ·  Hernia, Inguinal (1)  ·  Pelvic Organ Prolapse (1)  ·  Prolapse (1)  ·  Prostatic Hyperplasia (1)  ·  Thoracic Diseases (1)

Broader conditions

Female Urogenital Diseases (11)  ·  Female Urogenital Diseases and Pregnancy Complications (11)  ·  Male Urogenital Diseases (11)  ·  Urination Disorders (11)  ·  Urogenital Diseases (11)  ·  Urologic Diseases (11)  ·  Pathological Conditions, Anatomical (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Infections (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Hernia (1)  ·  Hernia, Abdominal (1)

Interventions

Tamsulosin (4)  ·  Glycopyrrolate (1)  ·  Magnesium Sulfate (1)  ·  Neostigmine (1)  ·  Nitrofurantoin (1)  ·  Phenazopyridine (1)  ·  Photoelectron Spectroscopy (1)  ·  Rocuronium (1)  ·  Sugammadex (1)  ·  calcium D-pantothenate, L-cysteine drug combination (1)  ·  ezogabine (1)

Sponsors

Wake Forest University Health Sciences (2)  ·  Antonio Nocito, MD (1)  ·  CHU de Reims (1)  ·  GlaxoSmithKline (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kantonsspital Graubünden (1)  ·  Memorial Health University Medical Center (1)  ·  Royal Victoria Hospital, Canada (1)  ·  University of Massachusetts, Worcester (1)  ·  University of Missouri-Columbia (1)

Countries

United States (7)  ·  France (2)  ·  Switzerland (2)  ·  Canada (1)  ·  Poland (1)

Top investigators

Antonio Nocito, Prof (1)  ·  Boris Mraovic, MD, FASA (1)  ·  Charles Ascher-Walsh, M.D. (1)  ·  Dina Bastawros, MD (1)  ·  Feiran Lou, MD (1)  ·  Majid Mirzazadeh, MD (1)  ·  Mostafa Elhilali, MD,PhD,FRCSC (1)

Results publications

PMID 33620905, PMID 34876420